Which pharmaceutical product innovation first successfully extended the dosing interval from daily to weekly or monthly for chronic disease management, creating a new standard for patient convenience?

The medical industry is constantly evolving with groundbreaking product innovations. One particular innovation revolutionized how patients manage chronic conditions by dramatically reducing administration frequency. This product innovation transformed the standard of care for millions of patients worldwide and represented a significant leap in medical technology. Test your knowledge about this game-changing pharmaceutical advancement that changed treatment paradigms.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Exenatide LAR (Bydureon) - First once-weekly GLP-1 receptor agonist for type 2 diabetes
Risperdal Consta - First atypical antipsychotic available as a long-acting injectable
Forteo - First anabolic agent for osteoporosis requiring daily self-injection
Rebif - First interferon beta-1a therapy for multiple sclerosis with titratable dosing